List of Tables
Table 1. Acute Viral Rhinosinusitis Treatment Market Trends
Table 2. Acute Viral Rhinosinusitis Treatment Market Drivers & Opportunity
Table 3. Acute Viral Rhinosinusitis Treatment Market Challenges
Table 4. Acute Viral Rhinosinusitis Treatment Market Restraints
Table 5. Global Acute Viral Rhinosinusitis Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Acute Viral Rhinosinusitis Treatment Revenue Market Share by Company (2019-2024)
Table 7. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Acute Viral Rhinosinusitis Treatment Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Acute Viral Rhinosinusitis Treatment Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Acute Viral Rhinosinusitis Treatment Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Acute Viral Rhinosinusitis Treatment Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Acute Viral Rhinosinusitis Treatment
Table 13. Global Acute Viral Rhinosinusitis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Viral Rhinosinusitis Treatment as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Acute Viral Rhinosinusitis Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Acute Viral Rhinosinusitis Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Acute Viral Rhinosinusitis Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Acute Viral Rhinosinusitis Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Acute Viral Rhinosinusitis Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Acute Viral Rhinosinusitis Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Acute Viral Rhinosinusitis Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Acute Viral Rhinosinusitis Treatment Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Acute Viral Rhinosinusitis Treatment Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Acute Viral Rhinosinusitis Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Acute Viral Rhinosinusitis Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Acute Viral Rhinosinusitis Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Acute Viral Rhinosinusitis Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Acute Viral Rhinosinusitis Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Acute Viral Rhinosinusitis Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Acute Viral Rhinosinusitis Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Acute Viral Rhinosinusitis Treatment Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Acute Viral Rhinosinusitis Treatment Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Acute Viral Rhinosinusitis Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Acute Viral Rhinosinusitis Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Acute Viral Rhinosinusitis Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Acute Viral Rhinosinusitis Treatment Sales Value by Region (2019-2024) & (%)
Table 44. Global Acute Viral Rhinosinusitis Treatment Sales Value by Region (2025-2030) & (%)
Table 45. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Region (2019-2024) & (%)
Table 49. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Region (2025-2030) & (%)
Table 50. Global Acute Viral Rhinosinusitis Treatment Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Acute Viral Rhinosinusitis Treatment Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Acute Viral Rhinosinusitis Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Acute Viral Rhinosinusitis Treatment Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Acute Viral Rhinosinusitis Treatment Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Acute Viral Rhinosinusitis Treatment Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Acute Viral Rhinosinusitis Treatment Sales Volume, (2025-2030) & (K Units)
Table 57. Sun Pharmaceutical Industries, Inc. Company Information
Table 58. Sun Pharmaceutical Industries, Inc. Introduction and Business Overview
Table 59. Sun Pharmaceutical Industries, Inc. Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Sun Pharmaceutical Industries, Inc. Acute Viral Rhinosinusitis Treatment Product Offerings
Table 61. Sun Pharmaceutical Industries, Inc. Recent Development
Table 62. Pfizer, Inc. Company Information
Table 63. Pfizer, Inc. Introduction and Business Overview
Table 64. Pfizer, Inc. Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Pfizer, Inc. Acute Viral Rhinosinusitis Treatment Product Offerings
Table 66. Pfizer, Inc. Recent Development
Table 67. Johnson & Johnson Company Information
Table 68. Johnson & Johnson Introduction and Business Overview
Table 69. Johnson & Johnson Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Johnson & Johnson Acute Viral Rhinosinusitis Treatment Product Offerings
Table 71. Johnson & Johnson Recent Development
Table 72. Fresenius Kabi USA, LLC Company Information
Table 73. Fresenius Kabi USA, LLC Introduction and Business Overview
Table 74. Fresenius Kabi USA, LLC Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Fresenius Kabi USA, LLC Acute Viral Rhinosinusitis Treatment Product Offerings
Table 76. Fresenius Kabi USA, LLC Recent Development
Table 77. Dr. Reddy's Laboratories, Inc. Company Information
Table 78. Dr. Reddy's Laboratories, Inc. Introduction and Business Overview
Table 79. Dr. Reddy's Laboratories, Inc. Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Dr. Reddy's Laboratories, Inc. Acute Viral Rhinosinusitis Treatment Product Offerings
Table 81. Dr. Reddy's Laboratories, Inc. Recent Development
Table 82. Novartis AG Company Information
Table 83. Novartis AG Introduction and Business Overview
Table 84. Novartis AG Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Novartis AG Acute Viral Rhinosinusitis Treatment Product Offerings
Table 86. Novartis AG Recent Development
Table 87. Teva Pharmaceutical Industries Ltd. Company Information
Table 88. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 89. Teva Pharmaceutical Industries Ltd. Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Teva Pharmaceutical Industries Ltd. Acute Viral Rhinosinusitis Treatment Product Offerings
Table 91. Teva Pharmaceutical Industries Ltd. Recent Development
Table 92. Sanofi Company Information
Table 93. Sanofi Introduction and Business Overview
Table 94. Sanofi Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Sanofi Acute Viral Rhinosinusitis Treatment Product Offerings
Table 96. Sanofi Recent Development
Table 97. Abbott Laboratories Company Information
Table 98. Abbott Laboratories Introduction and Business Overview
Table 99. Abbott Laboratories Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Abbott Laboratories Acute Viral Rhinosinusitis Treatment Product Offerings
Table 101. Abbott Laboratories Recent Development
Table 102. Bayer AG Company Information
Table 103. Bayer AG Introduction and Business Overview
Table 104. Bayer AG Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Bayer AG Acute Viral Rhinosinusitis Treatment Product Offerings
Table 106. Bayer AG Recent Development
Table 107. Eli Lilly and Company Company Information
Table 108. Eli Lilly and Company Introduction and Business Overview
Table 109. Eli Lilly and Company Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Eli Lilly and Company Acute Viral Rhinosinusitis Treatment Product Offerings
Table 111. Eli Lilly and Company Recent Development
Table 112. Bristol-Myers Squibb Company Information
Table 113. Bristol-Myers Squibb Introduction and Business Overview
Table 114. Bristol-Myers Squibb Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Bristol-Myers Squibb Acute Viral Rhinosinusitis Treatment Product Offerings
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Merck & Co, Inc. Company Information
Table 118. Merck & Co, Inc. Introduction and Business Overview
Table 119. Merck & Co, Inc. Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Merck & Co, Inc. Acute Viral Rhinosinusitis Treatment Product Offerings
Table 121. Merck & Co, Inc. Recent Development
Table 122. AstraZeneca plc Company Information
Table 123. AstraZeneca plc Introduction and Business Overview
Table 124. AstraZeneca plc Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. AstraZeneca plc Acute Viral Rhinosinusitis Treatment Product Offerings
Table 126. AstraZeneca plc Recent Development
Table 127. Amneal Pharmaceuticals LLC Company Information
Table 128. Amneal Pharmaceuticals LLC Introduction and Business Overview
Table 129. Amneal Pharmaceuticals LLC Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Amneal Pharmaceuticals LLC Acute Viral Rhinosinusitis Treatment Product Offerings
Table 131. Amneal Pharmaceuticals LLC Recent Development
Table 132. GlaxoSmithKline plc Company Information
Table 133. GlaxoSmithKline plc Introduction and Business Overview
Table 134. GlaxoSmithKline plc Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. GlaxoSmithKline plc Acute Viral Rhinosinusitis Treatment Product Offerings
Table 136. GlaxoSmithKline plc Recent Development
Table 137. Aurobindo Pharma Company Information
Table 138. Aurobindo Pharma Introduction and Business Overview
Table 139. Aurobindo Pharma Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Aurobindo Pharma Acute Viral Rhinosinusitis Treatment Product Offerings
Table 141. Aurobindo Pharma Recent Development
Table 142. Hikma Pharmaceuticals plc Company Information
Table 143. Hikma Pharmaceuticals plc Introduction and Business Overview
Table 144. Hikma Pharmaceuticals plc Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Hikma Pharmaceuticals plc Acute Viral Rhinosinusitis Treatment Product Offerings
Table 146. Hikma Pharmaceuticals plc Recent Development
Table 147. Wockhardt Company Information
Table 148. Wockhardt Introduction and Business Overview
Table 149. Wockhardt Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. Wockhardt Acute Viral Rhinosinusitis Treatment Product Offerings
Table 151. Wockhardt Recent Development
Table 152. Mylan N.V. Company Information
Table 153. Mylan N.V. Introduction and Business Overview
Table 154. Mylan N.V. Acute Viral Rhinosinusitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. Mylan N.V. Acute Viral Rhinosinusitis Treatment Product Offerings
Table 156. Mylan N.V. Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Acute Viral Rhinosinusitis Treatment Downstream Customers
Table 160. Acute Viral Rhinosinusitis Treatment Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Acute Viral Rhinosinusitis Treatment Product Picture
Figure 2. Global Acute Viral Rhinosinusitis Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Acute Viral Rhinosinusitis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Acute Viral Rhinosinusitis Treatment Sales Volume (2019-2030) & (K Units)
Figure 5. Global Acute Viral Rhinosinusitis Treatment Sales Price (2019-2030) & (US$/Unit)
Figure 6. Acute Viral Rhinosinusitis Treatment Report Years Considered
Figure 7. Global Acute Viral Rhinosinusitis Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Acute Viral Rhinosinusitis Treatment Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Acute Viral Rhinosinusitis Treatment Revenue in 2023
Figure 10. Acute Viral Rhinosinusitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. NSAIDS Picture
Figure 12. Saline Nasal Spray Picture
Figure 13. Nasal Corticosteroids Picture
Figure 14. Decongestants Picture
Figure 15. Global Acute Viral Rhinosinusitis Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Acute Viral Rhinosinusitis Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global Acute Viral Rhinosinusitis Treatment Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Acute Viral Rhinosinusitis Treatment Price by Type (2019-2030) & (US$/Unit)
Figure 20. Product Picture of Offline Pharmacy
Figure 21. Product Picture of E-Commerce
Figure 22. Global Acute Viral Rhinosinusitis Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Acute Viral Rhinosinusitis Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Acute Viral Rhinosinusitis Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Acute Viral Rhinosinusitis Treatment Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Acute Viral Rhinosinusitis Treatment Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America Acute Viral Rhinosinusitis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Acute Viral Rhinosinusitis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Acute Viral Rhinosinusitis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Acute Viral Rhinosinusitis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Acute Viral Rhinosinusitis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Acute Viral Rhinosinusitis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Acute Viral Rhinosinusitis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Acute Viral Rhinosinusitis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Acute Viral Rhinosinusitis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Acute Viral Rhinosinusitis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Acute Viral Rhinosinusitis Treatment Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Acute Viral Rhinosinusitis Treatment Sales Volume (%), (2019-2030)
Figure 39. United States Acute Viral Rhinosinusitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Acute Viral Rhinosinusitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Acute Viral Rhinosinusitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Acute Viral Rhinosinusitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Acute Viral Rhinosinusitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Acute Viral Rhinosinusitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. China Acute Viral Rhinosinusitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Acute Viral Rhinosinusitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. China Acute Viral Rhinosinusitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Acute Viral Rhinosinusitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Acute Viral Rhinosinusitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Acute Viral Rhinosinusitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Acute Viral Rhinosinusitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Acute Viral Rhinosinusitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Acute Viral Rhinosinusitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Acute Viral Rhinosinusitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Acute Viral Rhinosinusitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Acute Viral Rhinosinusitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 57. India Acute Viral Rhinosinusitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Acute Viral Rhinosinusitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 59. India Acute Viral Rhinosinusitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 60. Acute Viral Rhinosinusitis Treatment Industrial Chain
Figure 61. Acute Viral Rhinosinusitis Treatment Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
